AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19139323 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced office and patient management
Number of subjects: 599
Study 19139323 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored letter
Number of subjects: 599
Study 17338610 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 30 mg/kg intravenously as a bolus followed by a continuous infusion of 10 mg/kg/hr starting 15 minutes before induction of sedation.
Number of subjects: 50
Study 17338610 — intervention group
Group type: COMPARATOR
Intervention: Control group (no magnesium sulfate).
Number of subjects: 50
Study 15333537 — intervention group
Group type: EXPERIMENTAL
Intervention: Staples
Number of subjects: 20
Study 15333537 — intervention group
Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 20
Study 11370752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation of weekly fluoride rinsing (test group)
Number of subjects: 60
Study 11370752 — intervention group
Group type: COMPARATOR
Intervention: Weekly rinsing with 0.2% sodium fluoride solution (control group)
Number of subjects: 60
Study 9112137 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg x kg‐1 ketorolac
Number of subjects: 14
Study 9112137 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 mg x kg‐1 ketorolac
Number of subjects: 14
Study 1439621 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrotec (50 mg diclofenac + 200 micrograms misoprostol)
Number of subjects: 619
Study 1439621 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac (50 mg)
Number of subjects: 619
Study 4091997 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol consumption (80 g per day)
Number of subjects: 10
Study 4091997 — intervention group
Group type: COMPARATOR
Intervention: Control (abstinence from ethanol)
Number of subjects: 10
Study 30795711 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia educational intervention (4-week program followed by telephone consultations at Weeks 12 and 24)
Number of subjects: 123
Study 30795711 — intervention group
Group type: COMPARATOR
Intervention: Control group (no multimedia educational intervention)
Number of subjects: 123
Study 30813546 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan meal (V-meal)
Number of subjects: 20
Study 30813546 — intervention group
Group type: COMPARATOR
Intervention: Standard meat meal (M-meal)
Number of subjects: 20
Study 27770293 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Internet intervention (CheckYourDrinking.net)
Number of subjects: 490
Study 27770293 — intervention group
Group type: COMPARATOR
Intervention: Extended Internet intervention (AlcoholHelpCentre.net)
Number of subjects: 490
Study 27770293 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analyses of both interventions
Number of subjects: 490
Study 25779902 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus HN001 (HN001)
Number of subjects: 331
Study 25779902 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis HN019 (HN019)
Number of subjects: 331
Study 25779902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study 23344135 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality-targeted interventions for HR youth
Number of subjects: 2643
Study 23344135 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (statutory drug education) for LR youth
Number of subjects: 2643
Study 21155908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-intolerance (CI) to NSAIDs, primarily involving propionic acid derivatives like ibuprofen.
Number of subjects: 659
Study 21155908 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective responders (SR) to NSAIDs, primarily involving pyrazolones.
Number of subjects: 659
Study 19215336 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg entecavir
Number of subjects: 66
Study 19215336 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg entecavir
Number of subjects: 66
Study 17270090 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked meat meal
Number of subjects: 32
Study 17270090 — intervention group
Group type: COMPARATOR
Intervention: Meat-free meal
Number of subjects: 32
Study 14709952 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (1200 IU/d for 12 weeks)
Number of subjects: 41
Study 14709952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 11550573 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard inactivated whole‐virion influenza vaccine (0.5 ml subcutaneously in a single injection)
Number of subjects: 4518
Study 11550573 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard inactivated whole‐virion influenza vaccine (intranasally in two administrations)
Number of subjects: 4518
Study 11550573 — intervention group
Group type: COMPARATOR
Intervention: Standard inactivated whole‐virion influenza vaccine (intranasally)
Number of subjects: 4518
Study 11550573 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation 'Amber elixir plus'
Number of subjects: 4518
Study 9509882 — intervention group
Group type: EXPERIMENTAL
Intervention: Salford static knee instrument (SSKI)
Number of subjects: 14
Study 9509882 — intervention group
Group type: EXPERIMENTAL
Intervention: Al‐Turaiki device
Number of subjects: 14
Study 8112372 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 14C‐fosinoprilat (7.5 mg)
Number of subjects: 6
Study 8112372 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 14C‐fosinopril sodium (10 mg)
Number of subjects: 6
Study 8112372 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fosinopril sodium (10 mg)
Number of subjects: 6
Study 8112372 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinoprilat concentration vs. serum ACE activity
Number of subjects: 6
Study 8112372 — intervention group
Group type: COMPARATOR
Intervention: Haemodialysis (4 hours)
Number of subjects: 6
Study 3086388 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin therapy (5 days) in combination with penicillin or erythromycin (10-14 days)
Number of subjects: 9
Study 3086388 — intervention group
Group type: COMPARATOR
Intervention: Penicillin or erythromycin (10-14 days)
Number of subjects: 9
Study 2682692 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium addition to TCA
Number of subjects: 27
Study 2682692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 31926037 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood donors with lead concentrations over the limit for transfusions in premature infants (0.09 μmol/L)
Number of subjects: 0
Study 31926037 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood donors with mercury concentrations over the suggested limit (23.7 nmol/L)
Number of subjects: 0
Study 31926037 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood donors with cadmium concentrations over the limit (16 nmol/L)
Number of subjects: 0
Study 31926037 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood donors with perfluorooctanoate (PFOA) concentrations over the suggested limit (0.91 ng/mL)
Number of subjects: 0
Study 31926037 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood donors with perfluorooctane sulfonate (PFOS) concentrations over the suggested limit (0.91 ng/mL)
Number of subjects: 0
Study 31926037 — intervention group
Group type: EXPERIMENTAL
Intervention: PFAS and heavy metal concentrations in relation to donor's age
Number of subjects: 0
Study 31424677 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 102
Study 31424677 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 102
Study 27884065 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (ONA)
Number of subjects: 35
Study 27884065 — intervention group
Group type: EXPERIMENTAL
Intervention: Daewoong BTA (NBT)
Number of subjects: 35
Study 26406397 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week Nordic walking training program
Number of subjects: 32
Study 23609425 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced sputum (IS) analysis in patients with active sarcoidosis
Number of subjects: 86
Study 23609425 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum induction by inhalation of hypertonic saline
Number of subjects: 86
Study 22078240 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored nutrition intervention (five-a-day program)
Number of subjects: 400
Study 19451828 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 292
Study 19451828 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care antipsychotics
Number of subjects: 292
Study 16433729 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal alcohol monitoring device (anklet)
Number of subjects: 44
Study 16433729 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported drinking log and transdermal alcohol monitoring device
Number of subjects: 44
Study 16433729 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal alcohol monitoring device
Number of subjects: 44
Study 14654535 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐gamma (1.5 x 10(7) IU/instillation)
Number of subjects: 123
Study 14654535 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (40 mg/instillation)
Number of subjects: 123
Study 14654535 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐gamma
Number of subjects: 123
Study 10838647 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate vaccine (0.5 mL doses, groups 1 and 2; n=60 each)
Number of subjects: 182
Study 10838647 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B control vaccine (group 3; n=62)
Number of subjects: 182
Study 10452046 — intervention group
Group type: EXPERIMENTAL
Intervention: Local delivery of drugs (prednisolone and procaine) during tissue expansion
Number of subjects: 34
Study 10452046 — intervention group
Group type: COMPARATOR
Intervention: Control group (no local drug delivery)
Number of subjects: 34
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl (THP) 2 mg, 4 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Biperiden (BPD) 1 mg, 2 mg, 5 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazaticol (MZC) 4 mg, 8 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa (LDP) 100 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (BMC) 1.25 mg, 2.5 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine (AMD) 100 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (ATP) 25 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (HPD) 3 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (DZP) 3 mg
Number of subjects: 6
Study 1589555 — intervention group
Group type: COMPARATOR
Intervention: Inert placebo (PLB)
Number of subjects: 6
Study 3896595 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 56
Study 3896595 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg, b.d.)
Number of subjects: 56
Study 3896595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 29746229 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal and intravenous paclitaxel plus S-1 (IP); intraperitoneal paclitaxel 20 mg/m2 and intravenous paclitaxel 50 mg/m2 on days 1 and 8 plus S-1 80 mg/m2 per day on days 1 to 14 for a 3-week cycle
Number of subjects: 183
Study 29746229 — intervention group
Group type: COMPARATOR
Intervention: S-1 plus cisplatin (SP); S-1 80 mg/m2 per day on days 1 to 21 plus cisplatin 60 mg/m2 on day 8 for a 5-week cycle
Number of subjects: 183
Study 26732017 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-soluble cinnamon extract
Number of subjects: 428
Study 26732017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 428
Study 24665241 — intervention group
Group type: EXPERIMENTAL
Intervention: I.V ramosetron 0.3 mg
Number of subjects: 60
Study 24665241 — intervention group
Group type: COMPARATOR
Intervention: I.V Ondansetron 4 mg
Number of subjects: 60
Study 23460233 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone monotherapy, average dose 79.1±4.3 mg/kg/day
Number of subjects: 73
Study 23460233 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone monotherapy
Number of subjects: 73
Study 20434760 — intervention group
Group type: EXPERIMENTAL
Intervention: Template circumcision
Number of subjects: 30
Study 20434760 — intervention group
Group type: COMPARATOR
Intervention: Standard sleeve circumcision
Number of subjects: 30
Study 18403668 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg qd
Number of subjects: 21
Study 18403668 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide 640 microg bid
Number of subjects: 21
Study 18403668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 15733983 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous serum eyedrops
Number of subjects: 20
Study 15733983 — intervention group
Group type: COMPARATOR
Intervention: Preservative-free artificial tears
Number of subjects: 20
Study 11854905 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori infection
Number of subjects: 21
Study 9648571 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic acid 10% at pH 2.0
Number of subjects: 26
Study 9648571 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic acid 10% at pH 3.0
Number of subjects: 26
Study 9648571 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic acid 10% at pH 4.0
Number of subjects: 26
Study 9648571 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic acid 5% at pH 3.0
Number of subjects: 26
Study 9648571 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic acid 15% at pH 3.0
Number of subjects: 26
Study 9648571 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 26
Study 7653685 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy
Number of subjects: 84
Study 7653685 — intervention group
Group type: COMPARATOR
Intervention: Counseling plus supplemental drug counseling
Number of subjects: 84
Study 2527224 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin and netilmicin
Number of subjects: 21
Study 2527224 — intervention group
Group type: COMPARATOR
Intervention: Flucloxacillin and netilmicin
Number of subjects: 21
Study 791192 — intervention group
Group type: EXPERIMENTAL
Intervention: BA‐34647 (experimental antispasticity drug)
Number of subjects: 12
Study 791192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31847158 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue therapy (additional therapy program alongside standard physical therapy)
Number of subjects: 49
Study 31847158 — intervention group
Group type: COMPARATOR
Intervention: Standard physical therapy (control group)
Number of subjects: 49
Study 29454141 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Care worksite cessation program
Number of subjects: 126
Study 29454141 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 126
Study 27368000 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine (5 mg/kg)
Number of subjects: 68
Study 27368000 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam (0.7 mg/kg)
Number of subjects: 68
Study 25144127 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral MFLX (150 μg/mL) in left eye, balanced salt solution in right eye (Group A)
Number of subjects: 69
Study 25144127 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral MFLX (500 μg/mL in right eye, 150 μg/mL in left eye) (Group B)
Number of subjects: 69
Study 25144127 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral MFLX (150-500 μg/mL)
Number of subjects: 69
Study 25144127 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag and chamber flushing technique
Number of subjects: 69
Study 22124104 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus surgery (gemcitabine 1,250 mg/m² days 1 and 8 every 3 weeks plus cisplatin 75 mg/m² day 1 every 3 weeks followed by surgery)
Number of subjects: 270
Study 22124104 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 270
Study 22124104 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus surgery
Number of subjects: 270
Study 18930374 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside ultrasound performed by emergency physicians
Number of subjects: 6
Study 17488461 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar anaesthesia (RBA)
Number of subjects: 115
Study 17488461 — intervention group
Group type: COMPARATOR
Intervention: Topical anaesthesia (TA)
Number of subjects: 115
Study 17488461 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods of anaesthesia
Number of subjects: 115
Study 15127220 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic MRI (dMRI) in healthy volunteers
Number of subjects: 43
Study 15127220 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic MRI (dMRI) in patients with a tumor in the lower lung region
Number of subjects: 43
Study 15127220 — intervention group
Group type: COMPARATOR
Intervention: Dynamic MRI (dMRI) in patients with tumors of the upper and middle lung region
Number of subjects: 43
Study 11897280 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1
Number of subjects: 20
Study 11897280 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study 9568220 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine and prednisone
Number of subjects: 3
Study 7528662 — intervention group
Group type: EXPERIMENTAL
Intervention: Casodex 50 mg daily
Number of subjects: 28
Study 7528662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 2764059 — intervention group
Group type: COMPARATOR
Intervention: 6-week diet alone (24 to 30 kcal/kg/24 hours; 20% protein, 40% carbohydrate, 40% fat)
Number of subjects: 19
Study 2764059 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week diet plus exercise (20 minutes three times a week for 6 weeks)
Number of subjects: 19
Study 2764059 — intervention group
Group type: COMPARATOR
Intervention: 6-week diet alone
Number of subjects: 19
Study 2764059 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week diet plus exercise
Number of subjects: 19
Study 936381 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 125
Study 936381 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Number of subjects: 125
Study 936381 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 125
Study 31841026 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 25
Study 31841026 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 25
Study 31841026 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of dobutamine and terlipressin
Number of subjects: 25
Study 31841026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31152372 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL boluses of bupivacaine 0.125% with fentanyl 2 µg·mL-1
Number of subjects: 40
Study 28666474 — intervention group
Group type: EXPERIMENTAL
Intervention: AN69ST hemofilter
Number of subjects: 60
Study 28666474 — intervention group
Group type: COMPARATOR
Intervention: AN69 hemofilter
Number of subjects: 60
Study 26095142 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day
Number of subjects: 29
Study 26095142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 24125150 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol 80 μg
Number of subjects: 715
Study 24125150 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) nasal aerosol 160 μg
Number of subjects: 715
Study 24125150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 715
Study 21466994 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic cautery (UC)
Number of subjects: 40
Study 21466994 — intervention group
Group type: COMPARATOR
Intervention: High-frequency electrocautery (EC)
Number of subjects: 40
Study 21466994 — intervention group
Group type: EXPERIMENTAL
Intervention: Both UC and EC
Number of subjects: 40
Study 19683881 — intervention group
Group type: EXPERIMENTAL
Intervention: Artelon implant
Number of subjects: 53
Study 19683881 — intervention group
Group type: COMPARATOR
Intervention: APL tendon suspension interposition arthroplasty
Number of subjects: 53
Study 18184530 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal Supported Oral Treatment (BOT) - insulin glargine combined with glimepiride and metformin
Number of subjects: 10000
Study 18184530 — intervention group
Group type: COMPARATOR
Intervention: Conventional Therapy (CT) - premixed insulin
Number of subjects: 10000
Study 15056522 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with schizophrenia
Number of subjects: 42
Study 15056522 — intervention group
Group type: COMPARATOR
Intervention: Subjects with major depressive disorder
Number of subjects: 42
Study 15056522 — intervention group
Group type: COMPARATOR
Intervention: Comparison subjects with no psychiatric disorder
Number of subjects: 42
Study 11588126 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-managed approach using computerized tracking and universal colposcopy
Number of subjects: 54
Study 11588126 — intervention group
Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 54
Study 9413382 — intervention group
Group type: EXPERIMENTAL
Intervention: Javid shunt
Number of subjects: 163
Study 9413382 — intervention group
Group type: COMPARATOR
Intervention: Pruitt shunt
Number of subjects: 163
Study 1785707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clonidine (5 micrograms.kg‐1 during the first hour, and 0.3 microgram.kg‐1.h‐1 thereafter)
Number of subjects: 50
Study 1785707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 1785707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clonidine
Number of subjects: 50
Study 7265042 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard film taken during arterial time after contrast medium injection
Number of subjects: 3